213 related articles for article (PubMed ID: 24685170)
1. Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology.
Hendriks ME; Kundu P; Boers AC; Bolarinwa OA; Te Pas MJ; Akande TM; Agbede K; Gomez GB; Redekop WK; Schultsz C; Swan Tan S
Glob Health Action; 2014; 7():23573. PubMed ID: 24685170
[TBL] [Abstract][Full Text] [Related]
2. Costing Dengue Fever Cases and Outbreaks: Recommendations from a Costing Dengue Working Group in the Americas.
Constenla D; Armien B; Arredondo J; Carabali M; Carrasquilla G; Castro R; Durand L; Durán-Arenas L; García ME; Gallegos RV; Gontes ML; López JG; McFarlane C; Montoya R; Sartori AM; Siqueira JB; Martelli CT
Value Health Reg Issues; 2015 Dec; 8():80-91. PubMed ID: 29698176
[TBL] [Abstract][Full Text] [Related]
3. Costs of cardiovascular disease prevention care and scenarios for cost saving: a micro-costing study from rural Nigeria.
Hendriks ME; Bolarinwa OA; Nelissen HE; Boers AC; Gomez GB; Tan SS; Redekop W; Adenusi P; Lange JM; Agbede K; Akande TM; Schultsz C
J Hypertens; 2015 Feb; 33(2):376-684. PubMed ID: 25380164
[TBL] [Abstract][Full Text] [Related]
4. Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review.
Erfani P; Bhangdia K; Stauber C; Mugunga JC; Pace LE; Fadelu T
Oncologist; 2021 Aug; 26(8):e1406-e1417. PubMed ID: 34050590
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. The cost of injury and trauma care in low- and middle-income countries: a review of economic evidence.
Wesson HK; Boikhutso N; Bachani AM; Hofman KJ; Hyder AA
Health Policy Plan; 2014 Sep; 29(6):795-808. PubMed ID: 24097794
[TBL] [Abstract][Full Text] [Related]
7. Cost Evaluation of Minimally Invasive Tissue Sampling (MITS) Implementation in Low- and Middle-Income Countries.
Morrison LTR; Brown EG; Paganelli CR; Bhattarai S; Hailu R; Ntakirutimana G; Mbarushimana D; Subedi N; Goco N
Clin Infect Dis; 2021 Dec; 73(Suppl_5):S401-S407. PubMed ID: 34910172
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of vaccine preventable disease surveillance cost studies.
Erondu NA; Ferland L; Haile BH; Abimbola T
Vaccine; 2019 Apr; 37(17):2311-2321. PubMed ID: 30902482
[TBL] [Abstract][Full Text] [Related]
9. Estimating the costs of psychiatric hospital services at a public health facility in Nigeria.
Ezenduka C; Ichoku H; Ochonma O
J Ment Health Policy Econ; 2012 Sep; 15(3):139-48. PubMed ID: 23001282
[TBL] [Abstract][Full Text] [Related]
10. Methods for economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO Antenatal Care Randomised Controlled Trial.
Mugford M; Hutton G; Fox-Rushby J
Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():75-97. PubMed ID: 9805724
[TBL] [Abstract][Full Text] [Related]
11. An 8-step framework for implementing time-driven activity-based costing in healthcare studies.
da Silva Etges APB; Cruz LN; Notti RK; Neyeloff JL; Schlatter RP; Astigarraga CC; Falavigna M; Polanczyk CA
Eur J Health Econ; 2019 Nov; 20(8):1133-1145. PubMed ID: 31286291
[TBL] [Abstract][Full Text] [Related]
12. Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later.
Beck EJ; Avila C; Gerbase S; Harling G; De Lay P
Pharmacoeconomics; 2012 Oct; 30(10):887-902. PubMed ID: 22830633
[TBL] [Abstract][Full Text] [Related]
13. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies.
Leech AA; Kim DD; Cohen JT; Neumann PJ
Value Health; 2018 Jul; 21(7):759-761. PubMed ID: 30005746
[TBL] [Abstract][Full Text] [Related]
14. Cardiac rehabilitation in low- and middle-income countries: a review on cost and cost-effectiveness.
Oldridge NB; Pakosh MT; Thomas RJ
Int Health; 2016 Mar; 8(2):77-82. PubMed ID: 26208507
[TBL] [Abstract][Full Text] [Related]
15. Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations: a scoping review.
Fischer C; Mayer S; Perić N; Simon J
Health Econ Rev; 2022 Aug; 12(1):42. PubMed ID: 35920934
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.
Lin JK; Moran AE; Bibbins-Domingo K; Falase B; Pedroza Tobias A; Mandke CN; Kazi DS
Lancet Glob Health; 2019 Oct; 7(10):e1346-e1358. PubMed ID: 31477544
[TBL] [Abstract][Full Text] [Related]
17. How to develop cost-conscious guidelines.
Eccles M; Mason J
Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
[TBL] [Abstract][Full Text] [Related]
18. Standardisation of costs: the Dutch Manual for Costing in economic evaluations.
Oostenbrink JB; Koopmanschap MA; Rutten FF
Pharmacoeconomics; 2002; 20(7):443-54. PubMed ID: 12093300
[TBL] [Abstract][Full Text] [Related]
19. Cost of elective percutaneous coronary intervention in Malaysia: a multicentre cross-sectional costing study.
Lee KY; Ong TK; Low EV; Liow SY; Anchah L; Hamzah S; Liew HB; Ali RM; Ismail O; Ahmad WAW; Said MA; Dahlui M
BMJ Open; 2017 May; 7(5):e014307. PubMed ID: 28552843
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
